Dec 12. 2019
Yesterday morning, Zhejiang Qianming Plant Capsule Technology Co., Ltd. settled in Jiaxing and settled in the Innovation Building in Jiaxing Science and Technology City. At the unveiling ceremony, the company signed a cooperation agreement with Japan's Qianming Plant Capsule Co., Ltd. and Zhejiang Guangjuyuan Biotechnology Co., Ltd. to export Japanese plant capsules to 10 billion yen.
Zhejiang Qianming Plant Capsule is a Sino-Japanese joint venture. It has developed hypromellose hollow capsules under the support of the Chinese Ocean University and the Institute of Medicinal Plants of the Chinese Academy of Medical Sciences. It has reached the international advanced level and has been filed in the Japanese Ministry of Labour and Welfare, becoming the only Chinese capsule manufacturer to enter the Japanese market.
The Zhejiang Qianming Plant Capsule will be based in Jiaxing, with its R&D and sales headquarters. It is mainly based on Jiaxing's unique geographical advantages and convenient transportation. "There is also a very important point, that is, our partners and our production base - Guangjuyuan invites us to come here." Sun Mingming, the company's head. Originally established in 2015, Zhejiang Guangjuyuan Bio is located in Fengqiao Industrial Park, Nanhu District, Jiaxing City. It is a key investment enterprise in Jiaxing City and has an annual production capacity of 5 billion hypromellose hollow capsules.
Sun Zai Ming, a professor at the Institute of Medicinal Plants of the Chinese Academy of Medical Sciences, also came to the scene to give a high degree of recognition to Zhejiang Qianming plant capsules. "The development of plant capsules is promising. This cooperation is also of positive significance for Chinese medicine to enter the global market," he said. The reporter learned that the plant hollow capsule produced by Zhejiang Qianming Plant Capsule has the advantages of no pesticide residue, no genetically modified ingredients, no preservatives, etc., and low moisture content, suitable for moisture sensitive drugs, and will not be affected by external factors or internal medicines. Problems such as friability, adhesion, softening and deformation occur.
